Bingjie Hu

266 Xincun Xi Road, P.R. China
Zibo, 255000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Journal: Nature communications

Published: December 15, 2025

Identification of Cathepsin L as the Molecular Target of Hydroxychloroquine With Chemical Proteomics.

Identification of Cathepsin L as the Molecular Target of Hydroxychloroquine With Chemical Proteomics.

Journal: Molecular & cellular proteomics : MCP

Published: April 22, 2025

Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1.

Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1.

Journal: Nature communications

Published: April 10, 2025

Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia.

Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia.

Journal: Cell

Published: April 08, 2025

A review of electrospun metal oxide semiconductor-based photocatalysts.

A review of electrospun metal oxide semiconductor-based photocatalysts.

Journal: iScience

Published: January 27, 2025

A photostable luminescent iridium(III) complex probe for imaging endogenous mitochondrial sulfur dioxide in living cells.

A photostable luminescent iridium(III) complex probe for imaging endogenous mitochondrial sulfur dioxide in living cells.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: January 24, 2025

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Journal: Research square

Published: November 28, 2024

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Journal: Nature communications

Published: November 14, 2024

Microstructure of mixed κ- and ι-carrageenan gels viewed by rheology and solid-state NMR.

Microstructure of mixed κ- and ι-carrageenan gels viewed by rheology and solid-state NMR.

Journal: Journal of food science

Published: September 30, 2024

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.

Journal: Nature communications

Published: April 12, 2024

Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways.

Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways.

Journal: Journal of medical virology

Published: August 08, 2023

Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract.

Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract.

Journal: EBioMedicine

Published: July 31, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026